CD19 CAR T-Cell Therapy for Primary Mediastinal Large B-Cell Lymphoma: A CIBMTR Analysis.

Saved in:
Bibliographic Details
Title: CD19 CAR T-Cell Therapy for Primary Mediastinal Large B-Cell Lymphoma: A CIBMTR Analysis.
Authors: Gauthier J; Fred Hutchinson Cancer Center, Seattle, Washington, USA.; University of Washington, Seattle, Washington, USA., Ahn KW; Division of Biostatistics, Data Science Institute, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.; Center for International Blood and Marrow Research, Milwaukee, Wisconsin, USA., Patel J; Center for International Blood and Marrow Research, Milwaukee, Wisconsin, USA., Lian Q; Division of Biostatistics, Data Science Institute, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Badawy S; Northwestern University Feinberg School of Medicine, and Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA., Cairo MS; Maria Fareri Children's Hospital, Westchester Medical Center, New York Medical College, New York, New York, USA., Delgado J; Department of Hematology, Hospital Clinic de Barcelona, Barcelona, Spain., Grover N; Lineberger Comprehensive Cancer Center, Division of Hematology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA., Haverkos B; University of Colorado, Denver, Colorado, USA., de Lima M; Blood and Bone Marrow Transplant and Cellular Therapy Program at the Ohio State University, Columbus, Ohio, USA., Malone A; The Tisch Cancer Center, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Mussetti A; Clinical Hematology Department, Institut Català D'oncologia-L' Hospitalet, IDIBELL, Barcelona, Spain., Nieto Y; Department of Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, Houston, Texas, USA., Pawarode A; Blood and Marrow Transplant and Cellular Therapy Programs, Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA., Pearson L; UMass Chan Medical School/UMass Memorial Medical Center, Worcester, Massachusetts, USA., Solh M; Blood and Marrow Transplant Program at Northside Hospital, Atlanta, Georgia, USA., Sureda A; Department and Hematopoietic Stem Cell Transplant Programme, Institut Català d'Oncologia, Barcelona, Spain., Tun AM; Division of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas, Kansas City, Kansas, USA., Wudhikarn K; Division of Hematology and Center of Excellence in Translational Hematology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand., Yamshon S; Weill Cornell Medicine, New York, New York, USA., Shadman M; Fred Hutchinson Cancer Center, Seattle, Washington, USA.; University of Washington, Seattle, Washington, USA., Turtle CJ; University of Sydney, Sydney, New South Wales, Australia.; Royal North Shore Hospital, Sydney, New South Wales, Australia., Hamadani M; Divison of Hematology & Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Herrera AF; City of Hope National Medical Center, Duarte, California, USA.
Source: American journal of hematology [Am J Hematol] 2025 Oct; Vol. 100 (10), pp. 1792-1802. Date of Electronic Publication: 2025 Aug 11.
Publication Type: Journal Article; Multicenter Study; Observational Study; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural
Journal Info: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1096-8652
DOI:10.1002/ajh.70033